Your browser doesn't support javascript.
loading
Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants.
Lambertini, Matteo; Ceppi, Marcello; Hamy, Anne-Sophie; Caron, Olivier; Poorvu, Philip D; Carrasco, Estela; Grinshpun, Albert; Punie, Kevin; Rousset-Jablonski, Christine; Ferrari, Alberta; Paluch-Shimon, Shani; Toss, Angela; Senechal, Claire; Puglisi, Fabio; Pogoda, Katarzyna; Pérez-Fidalgo, Jose Alejandro; De Marchis, Laura; Ponzone, Riccardo; Livraghi, Luca; Estevez-Diz, Maria Del Pilar; Villarreal-Garza, Cynthia; Dieci, Maria Vittoria; Clatot, Florian; Duhoux, Francois P; Graffeo, Rossella; Teixeira, Luis; Córdoba, Octavi; Sonnenblick, Amir; Ferreira, Arlindo R; Partridge, Ann H; Di Meglio, Antonio; Saule, Claire; Peccatori, Fedro A; Bruzzone, Marco; t'Kint de Roodenbeke, Marie Daphne; Ameye, Lieveke; Balmaña, Judith; Del Mastro, Lucia; Azim, Hatem A.
Afiliação
  • Lambertini M; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy. matteo.lambertini@unige.it.
  • Ceppi M; Department of Medical Oncology, U.O.C, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy. matteo.lambertini@unige.it.
  • Hamy AS; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Caron O; Department of Medical Oncology, Institut Curie, Paris, France.
  • Poorvu PD; Department of Medical Oncology, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Carrasco E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Grinshpun A; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Punie K; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Rousset-Jablonski C; Department of General Medical Oncology and Multidisciplinary Breast Centre, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Ferrari A; Department of Surgery, Centre Léon Bérard, Lyon, France.
  • Paluch-Shimon S; Department of Surgical Sciences, General Surgery III - Breast Surgery, Fondazione IRCCS Policlinico San Matteo, University of Pavia, aBRCAdaBRA onlus, Pavia, Italy.
  • Toss A; Breast Oncology Unit, Shaare Zedek Medical Centre and Department of Oncology, Sheba Medical Center, Tel Hashomer, Jerusalem, Israel.
  • Senechal C; Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy.
  • Puglisi F; Cancer Genetics Unit, Bergonie Institute, Bordeaux, France.
  • Pogoda K; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Pérez-Fidalgo JA; Department of Medicine, University of Udine, Udine, Italy.
  • De Marchis L; Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Ponzone R; Department of Medical Oncology, INCLIVA University Hospital of Valencia, CIBERONC, Valencia, Spain.
  • Livraghi L; Division of Medical Oncology, Department of Radiological, Oncological and Pathological Sciences, "La Sapienza" University of Rome, Rome, Italy.
  • Estevez-Diz MDP; Gynecological Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Turin, Italy.
  • Villarreal-Garza C; Medical Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Dieci MV; University of Siena, Siena, Italy.
  • Clatot F; Departament of Oncology, Instituto do Cancer do Estado de Sao Paulo - Faculdade de Medicina da Universidade de Sao Paulo, Pacaembu, Sao Paulo, Brazil.
  • Duhoux FP; Department of Research and Breast Tumors, Mexican National Cancer Institute, Mexico City, Mexico.
  • Graffeo R; Breast Cancer Center, Hospital Zambrano Hellion, Tecnologico de Monterrey, San Pedro Garza Garcia, NL, Mexico.
  • Teixeira L; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Córdoba O; Medical Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
  • Sonnenblick A; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France.
  • Ferreira AR; Department of Medical Oncology, Breast Clinic, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium.
  • Partridge AH; Breast Unit of Southern Switzerland (CSSI), Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Di Meglio A; Breast Disease Unit, Saint-Louis Hospital, APHP, Université de Paris, INSERM U976, Paris, France.
  • Saule C; Obstetrics and Gynecology Department, Hospital Universitari Son Espases, Palma, Spain.
  • Peccatori FA; Oncology Division, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv, Israel.
  • Bruzzone M; Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.
  • t'Kint de Roodenbeke MD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ameye L; Predictive Biomarkers and New Therapeutic Strategies in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.
  • Balmaña J; Department of Genetics, Institut Curie, Paris, France.
  • Del Mastro L; Gynecologic Oncology Department, European Institute of Oncology IRCCS, Milan, Italy.
  • Azim HA; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
NPJ Breast Cancer ; 7(1): 16, 2021 Feb 12.
Article em En | MEDLINE | ID: mdl-33579978

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália